All Episodes

For Oncology Nurses: Strategies to Safely and Effectively Implement Antibody-Drug Conjugates — Proceedings from the 2026 Annual ONS Congress

Androgen Deprivation Therapy for Prostate Cancer — An Interview with Dr Rana R McKay

For Oncology Nurses: Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from the 2026 Annual ONS Congress

Targeted Therapies for Non-Small Cell Lung Cancer — Fifth Annual National General Medical Oncology Summit

HR-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit

Acute Myeloid Leukemia — Fifth Annual National General Medical Oncology Summit

Desmoid Tumors and Soft Tissue Sarcoma — Fifth Annual National General Medical Oncology Summit

EGFR-Mutated Non-Small Cell Lung Cancer — Fifth Annual National General Medical Oncology Summit

Metastatic Triple-Negative Breast Cancer — What Clinicians Want to Know

Urothelial Bladder Cancer — Year in Review Series on Relevant New Datasets and Advances

Myelofibrosis and Systemic Mastocytosis — Fifth Annual National General Medical Oncology Summit

For Oncology Nurses: Endometrial Cancer — Proceedings from the 2026 Annual ONS Congress

HER2-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit

Prostate Cancer — Fifth Annual National General Medical Oncology Summit

Colorectal Cancer — Fifth Annual National General Medical Oncology Summit

Triple-Negative Breast Cancer — Fifth Annual National General Medical Oncology Summit

Desmoid Tumors — Microlearning Activity 4 with Prof Bernd Kasper

Ovarian Cancer — Fifth Annual National General Medical Oncology Summit

Gastroesophageal Cancers — Fifth Annual National General Medical Oncology Summit

Multiple Myeloma — Fifth Annual National General Medical Oncology Summit

First-Line and Maintenance Therapy for Patients with Extensive-Stage Small Cell Lung Cancer — An Interview with Prof Martin Reck

Urothelial Bladder Cancer — Fifth Annual National General Medical Oncology Summit

HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer

Chronic Lymphocytic Leukemia — Fifth Annual National General Medical Oncology Summit

Prostate Cancer — Proceedings from a Session Held in Conjunction with the 2026 American Urological Association Annual Meeting

Pancreatic Cancer — Fifth Annual National General Medical Oncology Summit

Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Fifth Annual National General Medical Oncology Summit

Localized Renal Cell Carcinoma — Proceedings from a Session Held in Conjunction with the 2026 American Urological Association Annual Meeting

HR-Positive Metastatic Breast Cancer — A Discussion and Debate on First- and Second-Line Therapy

Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances

Genitourinary Cancers — 5-Minute Journal Club Issue 2 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

Antibody-Drug Conjugates in Gynecologic Cancers — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer

Desmoid Tumors — Microlearning Activity 3 with Prof Bernd Kasper

Colorectal Cancer — Year in Review Series on Relevant New Datasets and Advances

Genitourinary Cancers — 5-Minute Journal Club Issue 1 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances

Ovarian Cancer — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women’s Cancer

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 4: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium

PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer — An Interview with Dr Wassim Abida

Immunotherapy for Endometrial Cancer — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women’s Cancer

Oncology Nursing Update: Nonmelanoma Skin Cancers — An Interview with Dr Nikhil Khushalani

Localized Colorectal Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium

Oral SERDs for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium

Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances

Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances

Lung Cancer — 5-Minute Journal Club with Dr Natalie Vokes: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Optimizing Biomarker Assessment and Related Treatment Decision-Making

Metastatic Bladder Cancer — Rapid Case Review Issue 4

ER-Positive, HER2-Positive Metastatic Breast Cancer — What Clinicians Want to Know About First-Line and Maintenance Therapy

Localized Colorectal Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium

CELMoDs for Multiple Myeloma — Microlearning Activity 2 with Dr Paul G Richardson

HER2-Positive Gastrointestinal Cancers — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium

Desmoid Tumors — Microlearning Activity 2 with Dr Ravin Ratan

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium

Nonmelanoma Skin Cancers — A Roundtable Discussion on the Multidisciplinary Management of Cutaneous Squamous Cell and Basal Cell Carcinomas

Immune Thrombocytopenia — Microlearning Activity 4 with Dr Hanny Al-Samkari: ASH 2025 Review

AKT Inhibition in Prostate Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium

Diabetology in Breast Cancer — Managing Hyperglycemia in Patients with Breast Cancer Receiving Agents Targeting the PI3K/AKT/PTEN Pathway

Metastatic Bladder Cancer — Rapid Case Review Issue 3

Localized Colorectal Cancer — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium

Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium

CELMoDs for Multiple Myeloma — Microlearning Activity 1 with Dr Paul G Richardson

Immune Thrombocytopenia — Microlearning Activity 3 with Dr Hanny Al-Samkari: ASH 2025 Review

HER2-Positive Gastrointestinal Cancers — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium

Breast Cancer — 5-Minute Journal Club Issue 2 with Dr Lajos Pusztai: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

Desmoid Tumors — Microlearning Activity 1 with Dr Ravin Ratan

HER2-Positive Gastrointestinal Cancers — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium

CD19 x CD3 BiTEs for Acute Lymphoblastic Leukemia — An Interview with Dr Bijal Shah

Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Presentations from the 2025 ASH Annual Meeting

Immune Thrombocytopenia — Microlearning Activity 2 with Dr Hanny Al-Samkari: ASH 2025 Review

Ovarian Cancer — Year in Review Series on Relevant New Datasets and Advances

Immune Thrombocytopenia — Microlearning Activity 1 with Dr Hanny Al-Samkari: ASH 2025 Review

Antibody-Drug Conjugates for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

Extensive-Stage Small Cell Lung Cancer — Current Patterns of Care with First-Line and Maintenance Therapy

Colorectal Cancer — A Roundtable Discussion on the Use of Molecular Residual Disease Analysis

Urothelial Bladder Cancer — Microlearning Activity 2 with Dr Terence Friedlander: ESMO Congress 2025 Review

Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators

Metastatic Bladder Cancer — Rapid Case Review Issue 2

Gynecologic Cancers — Highlights from the 2025 ESMO Annual Meeting

Relapsed/Refractory Multiple Myeloma — Microlearning Activity 2 with Dr Sagar Lonial: ASH 2025 Review

Squamous Cell Carcinoma of the Anal Canal — An Interview with Dr Marwan Fakih

Prostate Cancer — Microlearning Activity 2 with Dr Rana R McKay: ESMO Congress 2025 Review

Antibody-Drug Conjugates for Ovarian Cancer — An Interview with Dr Kathleen N Moore

Localized Colorectal Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Gastrointestinal Cancers Symposium

Immune Thrombocytopenia — ASH 2025 Review

Urothelial Bladder Cancer — Microlearning Activity 1 with Dr Terence Friedlander: ESMO Congress 2025 Review

Relapsed/Refractory Multiple Myeloma — Microlearning Activity 1 with Dr Sagar Lonial: ASH 2025 Review

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Proceedings from a Session Held Adjunct to the 2026 ASCO Gastrointestinal Cancers Symposium

Prostate Cancer — Microlearning Activity 1 with Dr Rana R McKay: ESMO Congress 2025 Review

HER2-Positive Gastrointestinal Cancers — Proceedings from a Session Held Adjunct to the 2026 ASCO Gastrointestinal Cancers Symposium

Endocrine-Based Therapy for HR-Positive Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series

Metastatic Bladder Cancer — Rapid Case Review Issue 1

Bispecific Antibodies in the Management of Lymphoma — ASH 2025 Review

Relapsed/Refractory Multiple Myeloma — ASH 2025 Review

HER2-Positive Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series

Follicular Lymphoma and Diffuse Large B-Cell Lymphoma — Proceedings from a Symposium Series Preceding the 67th ASH Annual Meeting and Exposition

Colorectal Cancer — 5-Minute Journal Club Issue 2 with Dr Scott Kopetz: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

Myelofibrosis and Systemic Mastocytosis — Proceedings from a Symposium Series Preceding the 67th ASH Annual Meeting and Exposition

Antibody-Drug Conjugates for Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series

Chronic Lymphocytic Leukemia — Proceedings from a Symposium Series Preceding the 67th ASH Annual Meeting and Exposition

Colorectal Cancer — 5-Minute Journal Club Issue 1 with Dr Scott Kopetz: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

Acute Myeloid Leukemia — Proceedings from a Symposium Series Preceding the 67th ASH Annual Meeting and Exposition

Toxicities Associated with Antibody-Drug Conjugates for Metastatic Breast Cancer — Clinical Investigator Perspectives on Actual Patient Cases

Advanced Gastroesophageal Cancers — Expert Perspectives on Actual Patient Cases: Part 2 of 2

Urothelial Bladder Cancer and Prostate Cancer — Highlights from the 2025 ESMO Annual Meeting

Extensive-Stage Small Cell Lung Cancer — What Clinicians Want to Know About First-Line and Maintenance Therapy

Gastroesophageal Cancers — Proceedings from a Symposium Held in Partnership with the American Oncology Network

Ovarian Cancer — Proceedings from a Symposium Held in Partnership with the American Oncology Network

Chronic Lymphocytic Leukemia — Proceedings from a Symposium Held in Partnership with the American Oncology Network

Lung Cancer — Proceedings from a Symposium Held in Partnership with the American Oncology Network

CAR T-Cell Therapy for Non-Hodgkin Lymphoma | Cancer Q&A — Discussing Common Questions Posed by Patients

HER2-Altered Non-Small Cell Lung Cancer — An Interview with Dr John V Heymach

Breast Cancer — Highlights from the 2025 ESMO Annual Meeting

Breast Cancer — Microlearning Activity Issue 3 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates

Toxicities Associated with CAR T-Cell Therapy — An Interview with Dr Matthew Lunning

Breast Cancer — Microlearning Activity 2 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates

Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 2

Breast Cancer — Microlearning Activity 1 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates

HER2-Positive Gastrointestinal Cancers — Clinical Investigator Perspectives on Actual Patient Cases

HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders

Patient Education Resource: Non-Hodgkin Lymphoma — Clinical Experts Address Common Questions Posed by Patients About CAR T-Cell Therapy

ER-Positive Metastatic Breast Cancer — A Roundtable Discussion on the Current and Future Role of Oral SERDs

Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute

Colorectal Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute

Prostate Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute

Breast Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute

Lung Cancer — 5-Minute Journal Club Issue 4 with Dr Aaron Lisberg: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

Endometrial Cancer — Clinical Investigator Perspectives on Actual Patient Cases

ER-Positive Metastatic Breast Cancer — An Interview with Prof Patrick Neven on the Role of Oral Selective Estrogen Receptor Degraders

Colorectal Cancer — An Interview with Dr John Strickler on Molecular Residual Disease Analysis

Breast Cancer — 5-Minute Journal Club Issue 4 with Dr Kevin Kalinsky: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

Acute Myeloid Leukemia — An Interview with Dr Eunice S Wang to Review Key Presentations from ASCO and EHA

Metastatic Breast Cancer — Current and Future Integration of Antibody-Drug Conjugates

Lung Cancer — 5-Minute Journal Club Issue 3 with Dr Aaron Lisberg: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

Non-Hodgkin Lymphoma — The Implications of Recent Datasets for Current and Future Disease Management

HR-Positive and Triple-Negative Metastatic Breast Cancer — An Interview with Dr Laura Huppert on Optimal Integration of ADCs into Treatment

Follicular Lymphoma — Proceedings from a Session Held During the Society of Hematologic Oncology 2025 Annual Meeting

Acute Myeloid Leukemia — An Interview with Dr Ghayas Issa on the Role of Menin Inhibitors

Breast Cancer — An ASCO 2025 Review

Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held During the Society of Hematologic Oncology 2025 Annual Meeting

Breast Cancer — 5-Minute Journal Club Issue 3 with Dr Kevin Kalinsky: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

Metastatic BRCA-Negative, Triple-Negative Breast Cancer — An Interview with Prof Peter Schmid on Optimal Management

Extrapulmonary Neuroendocrine Carcinoma — An Interview with Dr Jonathan Strosberg on Current and Future Management

Oncology Nursing Update: Multiple Myeloma — An Interview with Dr Beth Faiman on CAR T-Cell Therapy

Metastatic Triple-Negative Breast Cancer — The Selection and Sequencing of Therapy

Ocular Toxicities Associated with Antibody-Drug Conjugates and Other Cancer Therapies: Part 2 — An Interview with Dr Neel Pasricha on Adverse Event Management

Ocular Toxicities Associated with Antibody-Drug Conjugates and Other Cancer Therapies: Part 1 — Inside the Issue of Adverse Event Management

Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 2 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 1

Oncology Nursing Update: Newly Diagnosed Multiple Myeloma — An Interview with Ms Charise Gleason

Oncology Nursing Update: Newly Diagnosed Multiple Myeloma — An Interview with Prof Xavier Leleu

Breast Cancer — 5-Minute Journal Club Issue 2 with Dr Erika Hamilton: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

Relapsed/Refractory Multiple Myeloma — Oncology Q&A: Discussing Common Questions Posed by Patients

Biliary Tract Cancers — Expert Perspectives on Actual Patient Cases: Part 2 of 2

Brain Metastases with HER2-Positive Breast Cancer — An Interview with Dr Sarah Sammons on Optimal Management Approaches

Small Cell Lung Cancer — Expert Perspectives on Actual Patient Cases

Ovarian and Endometrial Cancer — An Interview with Dr Shannon Westin on the Current Management Paradigm

Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 1 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

Multiple Myeloma | Oncology Q&A — Patient Education Resource: Clinical Experts Address Common Questions Posed by Patients with Relapsed/Refractory Multiple Myeloma

Acute Myeloid Leukemia — An Interview with Dr Jorge Cortes on Optimal Management of FLT3 and IDH1/2 Mutations

Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances

Multiple Myeloma — Optimizing the Selection of First-Line Therapy

Breast Cancer — 5-Minute Journal Club Issue 1 with Dr Erika Hamilton: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

Gynecologic Cancers — Year in Review Series on Relevant New Datasets and Advances

Oncology Nursing Update: Prostate Cancer — An Interview with Ms Kathleen D Burns on the Current Treatment Paradigm and New Approaches to Patient Care

Endocrine-Resistant HR-Positive Metastatic Breast Cancer — An Interview with Dr Hope S Rugo on Optimal Management

Soft Tissue Sarcoma and Other Connective Tissue Neoplasms — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting

Renal Cell Carcinoma — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting

Chronic Lymphocytic Leukemia — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

Oncology Nursing Update: Ovarian Cancer — An Interview with Ms Jennifer Filipi on the Current Treatment Paradigm and New Approaches

Multiple Myeloma — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting

Lung Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting on the Current and Future Role of Immunotherapy and Antibody-Drug Conjugates

For Oncology Nurses: Prostate Cancer — Proceedings from the 2025 Annual ONS Congress

HER2-Positive Gastrointestinal Cancers — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

For Oncology Nurses: Chronic Lymphocytic Leukemia — Proceedings from the 2025 Annual ONS Congress

Urothelial Bladder Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

Non-Hodgkin Lymphoma — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

For Oncology Nurses: DLL3-Targeting Bispecific T-Cell Engagers for Small Cell Lung Cancer — Proceedings from the 2025 Annual ONS Congress

For Oncology Nurses: Non-Hodgkin Lymphoma — Proceedings from the 2025 Annual ONS Congress

Metastatic Breast Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

Colorectal Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

Ovarian and Endometrial Cancer  — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

For Oncology Nurses: Chronic Myeloid Leukemia — Proceedings from the 2025 Annual ONS Congress

Prostate Cancer  — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

For Oncology Nurses: Ovarian Cancer — Proceedings from the 2025 Annual ONS Congress

IDH-Mutant Low-Grade Glioma — An Interview with Dr Patrick Y Wen on Current and Future Management Strategies

EGFR Mutation-Positive Non-Small Cell Lung Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

Advanced Gastroesophageal Cancers — Expert Perspectives on Actual Patient Cases: Part 1 of 2

Multiple Myeloma — Year in Review Series on Relevant New Datasets and Advances

For Oncology Nurses: Hormone Receptor-Positive Breast Cancer — Proceedings from the 2025 Annual ONS Congress

For Oncology Nurses: Gastroesophageal Cancer — Proceedings from the 2025 Annual ONS Congress

Myelofibrosis — Year in Review Series on Relevant New Datasets and Advances

Non-Small Cell Lung Cancer and Therapeutic Targets Beyond EGFR — Year in Review Series on Relevant New Datasets and Advances

For Oncology Nurses: Endometrial Cancer — Proceedings from the 2025 Annual ONS Congress

Non-Hodgkin Lymphoma — Year in Review Series on Relevant New Datasets and Advances

Breast Cancer: Additional Perspectives — Year in Review Series on Relevant New Datasets and Advances

Prostate Cancer and AKT Inhibitors — Proceedings from a Session Held During the American Urological Association Annual Meeting

Systemic Mastocytosis and Myelofibrosis — Fourth Annual National General Medical Oncology Summit

Hepatocellular Carcinoma — Fourth Annual National General Medical Oncology Summit

Multiple Myeloma — Fourth Annual National General Medical Oncology Summit

For Oncology Nurses: Pancreatic Cancer — Proceedings from the 2025 Annual ONS Congress

Multiple Myeloma — An Interview with Dr Rafael Fonseca on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting

5-Minute Journal Club Issue 8 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Gastroesophageal Cancer — Fourth Annual National General Medical Oncology Summit

Chronic Lymphocytic Leukemia — An Interview with Dr Lindsey Roeker on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting

Relapsed/Refractory Follicular Lymphoma Part 3 — A Roundtable Discussion on the Selection and Sequencing of Other Novel Therapies

Urothelial Bladder Cancer — Fourth Annual National General Medical Oncology Summit

Pancreatic Cancer — Fourth Annual National General Medical Oncology Summit

Non-Hodgkin Lymphoma — An Interview with Dr Jennifer Crombie on the Use of Bispecific Antibodies

5-Minute Journal Club Issue 7 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Immunotherapy and Nontargeted Approaches for NSCLC — Fourth Annual National General Medical Oncology Summit

Colorectal Cancer — Fourth Annual National General Medical Oncology Summit

Relapsed/Refractory Follicular Lymphoma Part 2 — A Roundtable Discussion on the Selection and Sequencing of CAR T-Cell Therapy

Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances

Non-Hodgkin Lymphoma — Fourth Annual National General Medical Oncology Summit

Gynecologic Cancers — Fourth Annual National General Medical Oncology Summit

Non-Hodgkin Lymphoma — An Interview with Dr John P Leonard on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting

Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances

EGFR Mutation-Positive NSCLC — Fourth Annual National General Medical Oncology Summit

Prostate Cancer — Fourth Annual National General Medical Oncology Summit

Immune Thrombocytopenia — A Roundtable Discussion on Current and Future Management Strategies

Biliary Tract Cancers — Fourth Annual National General Medical Oncology Summit

For Oncology Nurses: Antibody-Drug Conjugates for Breast Cancer and Lung Cancer — Proceedings from the 2025 Annual ONS Congress

Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy

Genitourinary Cancers — An Interview with Dr William K Oh on Recent Trial Updates

Relapsed/Refractory Follicular Lymphoma Part 1 — A Roundtable Discussion on the Selection and Sequencing of Bispecific Antibodies

HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit

Oncology Nursing Update Special 2-Part Edition: Bispecific Antibodies in Lymphoma — Part 2

Ovarian Cancer — Proceedings from a Session Held During the 2025 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer®️

Myelofibrosis — An Interview with Dr Raajit K Rampal on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting

Sarcoma and Other Connective Tissue Neoplasms — Fourth Annual National General Medical Oncology Summit

HR-Positive Breast Cancer — Fourth Annual National General Medical Oncology Summit

Chronic Lymphocytic Leukemia — Fourth Annual National General Medical Oncology Summit

Neuroendocrine Tumors — Fourth Annual National General Medical Oncology Summit

First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor

Breast Cancer — An Interview with Dr Adrienne G Waks on Recent Trial Updates

Chronic Lymphocytic Leukemia — An Interview with Dr Catherine C Coombs on Real-World Cases and Current Questions and Controversies Presented at Recent Conferences

HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the 2025 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer®️

HR-Positive Breast Cancer — An Interview with Dr Sara A Hurvitz on the Role of Endocrine-Based Therapy

For Oncology Nurses: Bispecific Antibodies in Multiple Myeloma — An Interview with Dr Tiffany A Richards

5-Minute Journal Club Issue 6 with Dr Komal Jhaveri: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Neurofibromatosis Type 1 Plexiform Neurofibromas — An interview with Dr Christopher L Moertel

Oncology Nursing Update Special 2-Part Edition: Bispecific Antibodies in Lymphoma — Part 1

Renal Cell Carcinoma — Proceedings from a Session Held in Conjunction with the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU)

Colorectal Cancer — Year in Review Series on Relevant New Datasets and Advances

Localized Breast Cancer — Examining the Current Use of Genetic Testing and Related Clinical Management

Urothelial Bladder Cancer and Prostate Cancer — Proceedings from a Session Held in Conjunction with the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU)

5-Minute Journal Club Issue 5 with Dr Komal Jhaveri: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Biliary Tract Cancers — Reviewing Patient Cases with Prof John Bridgewater: Part 1 of 2

Relapsed/Refractory Diffuse Large B-Cell Lymphoma — A Roundtable Discussion on Current and Future Management Strategies

Colorectal Cancer — Proceedings from a Session Held in Conjunction with the 2025 ASCO Gastrointestinal Cancers Symposium (ASCO GI)

Multiple Myeloma — An Interview with Dr Surbhi Sidana on Optimizing the Role of CAR T-Cell Therapy

HER2-Low and HER2-Ultralow Breast Cancer — A Roundtable Discussion on Current and Future Management Strategies

Hepatocellular Carcinoma — Proceedings From a Session Held in Conjunction with the 2025 ASCO Gastrointestinal Cancers Symposium (ASCO GI)

5-Minute Journal Club Issue 4 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances

Multiple Myeloma — Optimizing the Selection of First-Line Therapy with Dr Saad Zafar Usmani

5-Minute Journal Club Issue 3 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Chronic Lymphocytic Leukemia with Dr Jennifer Woyach: Part 3 of a 3-Part Meet The Professor Series

Metastatic Triple-Negative Breast Cancer — Oncology Q&A for Clinicians: Discussing Common Questions Posed by Patients

Data + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Oncology Q&A for Patients with Metastatic Triple-Negative Breast Cancer

CAR T-Cell and Bispecific Therapy for Lymphoma — Part 3 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

Myelofibrosis — Part 4 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

Metastatic Breast Cancer — San Antonio 2024 symposium series proceedings Part 3

Chronic Myeloid Leukemia — Part 1 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

Acute Myeloid Leukemia — Part 5 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

The Role of Endocrine-Based Therapy in the Management of Breast Cancer — San Antonio 2024 symposium series proceedings Part 2

HER2-Low and HER2-Ultralow Breast Cancer — San Antonio 2024 symposium series proceedings Part 1

Multiple Myeloma — Part 6 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

Chronic Lymphocytic Leukemia — Part 2 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

Cases from the Community: Integrating New Research Findings into Current Practice — Colorectal and Gastroesophageal Cancers

Cases from the Community: Integrating New Research Findings into Current Practice — Hepatobiliary Cancers

Cases from the Community: Integrating New Research Findings into Current Practice — Gynecologic Cancers

Cases from the Community: Integrating New Research Findings into Current Practice — Myelofibrosis

Cases from the Community: Integrating New Research Findings into Current Practice — Leukemia and Myelodysplastic Syndromes

Cases from the Community: Integrating New Research Findings into Current Practice — Lung Cancer

5-Minute Journal Club Issue 2 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Meet The Professor: Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review

Exploring the Current Management Paradigm for Patients with Metastatic Triple-Negative Breast Cancer

Practical Perspectives: Investigators Discuss the Current Management of Paroxysmal Nocturnal Hemoglobinuria

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Multiple Myeloma

5-Minute Journal Club Issue 1 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

The Implications of Recent Datasets for the Current and Future Management of Lung Cancer — A Review of Information from ESMO Congress 2024 and Other Conferences

Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 2 of a 3-Part Series

Optimizing the Management of Tenosynovial Giant Cell Tumor

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Prostate Cancer

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Optimizing Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Lung Cancer

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care — Breast Cancer

What Clinicians Want to Know About the Current and Future Role of EZH1/2 Inhibitors in the Care of Patients with Lymphoma

Special Edition — Key Presentations on Lung Cancer from Recent Major Conferences

The Implications of Recent Datasets for the Current and Future Management of Gastrointestinal Cancers — An ESMO Congress 2024 Review

Improving Outcomes with First-Line Endocrine-Based Therapy for Patients with HR-Positive, HER2-Negative Metastatic Breast Cancer

Practical Perspectives: Optimizing the Role of BTK Inhibitors in the Management of Mantle Cell Lymphoma

Potential Role of PROTAC ER Degraders in Therapy for HR-Positive Metastatic Breast Cancer

Practical Perspectives: Current Management of Chronic Myeloid Leukemia

The Implications of Recent Datasets for the Current and Future Management of Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review

Practical Perspectives: Optimizing Diagnosis and Treatment for Patients with Desmoid Tumors

Peripheral T-Cell Lymphoma

The Implications of Recent Datasets for the Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer

Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 1 of a 3-Part Series

The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with Actionable Targets Beyond EGFR

The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with EGFR Mutations

Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer

Striving for Consensus: Optimizing the Current and Future Management of Biliary Tract Cancers

Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors

Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers

Optimizing the Management of Dedifferentiated Liposarcoma

Inside the Issue: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer

Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation

Management of Metastatic Urothelial Bladder Cancer

Special Edition — Key Presentations on Breast Cancer from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

An interview with Professor Giuseppe Curigliano, MD, PhD — Management of Metastatic Breast Cancer

An interview with Angeles Alvarez Secord, MD, MHSc — Management of Ovarian and Endometrial Cancer

Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer

Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer

Novel Agents and Strategies in Lung Cancer

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers

Individualizing the Selection of First-Line Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer

An interview with Matthew R Smith, MD, PhD — Management of Prostate Cancer

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer

Optimizing the Identification of HER2-Low Breast Cancer

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology

An interview with Jonathan W Goldman, MD — Management of Non-Small Cell Lung Cancer with an EGFR Mutation

Investigator Perspectives on Available Research and Challenging Questions in Melanoma and Nonmelanoma Skin Cancers: A Post-ASCO 2024 Annual Review

Investigator Perspectives on Available Research and Challenging Questions in Renal Cell Carcinoma: A Post-ASCO Annual Review

RTP Live from Chicago: Investigator Perspectives on Recent Advances and Challenging Questions in the Management of Colorectal Cancer

RTP Live from Chicago: Investigator Perspectives on the Role of Bispecific Antibodies in the Management of Lymphoma

What Clinicians Want to Know About the Management of Triple-Negative Breast Cancer

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Myelofibrosis

Clinical Update on the Current Management of Advanced Urothelial Bladder Cancer

Striving for Consensus: Exploring the Current Role of Ovarian Suppression in the Management of Breast Cancer

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer

Second Opinion: Urologic Oncology Investigators Discuss How They Apply Clinical Research in the Care of Patients with Urothelial Bladder Cancer

Key Presentations on Lymphoma from Recent Major Conferences

Bispecific Antibodies in the Management of Multiple Myeloma

Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia

Virtual Case Library: Metastatic Triple-Negative Breast Cancer

Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition

Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer

Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series

Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria

Special Edition – Prostate Cancer Updates from a CME Program Held at the 2024 Genitourinary Cancers Symposium

Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences

Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition

Key Presentations on Chronic Lymphocytic Leukemia from Recent Major Conferences

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Urothelial Bladder Cancer

The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma

Overcoming Endocrine Resistance in ER-Positive Metastatic Breast Cancer

Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review

Promising Therapeutic Strategies for Patients with Progressive Metastatic Non-Small Cell Lung Cancer

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer

Virtual Case Library: Metastatic Urothelial Bladder Cancer

Understanding the Current and Future Role of Oral SERDs (Selective Estrogen Receptor Degraders) in the Management of ER-Positive Metastatic Breast Cancer

Meet The Professor: Optimizing the Management of Myelofibrosis — Part 1 of a 2-Part Series

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gastroesophageal Cancers

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia

Consensus or Controversy? Investigator Perspectives on the Current and Future Role of Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers

Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 4 of a 4-Part Series

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hormone Receptor-Positive Breast Cancer

Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 3 of a 4-Part Series

Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 3 of a 3-Part Series

Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gynecologic Cancers — Part 1 of a Special 3-Part Edition

Inside the Issue: Targeted and Immunotherapeutic Approaches for Biliary Tract Cancers

Implications of Recent Data Sets for the Current and Future Management of Lung Cancer

Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 3 of a 3-Part Series

Implications of Recent Data Sets for the Current and Future Management of Breast Cancer

Implications of Recent Data Sets for the Current and Future Management of Gynecologic Cancers

Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 2 of a 3-Part Series

Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 2 of a 3-Part Series

Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 2 of a 4-Part Series

Inside the Issue: Optimizing the Management of Nonmelanoma Skin Cancer

Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 1 of a 3-Part Series

Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 1 of a 3-Part Series

What Clinicians Want to Know About the Management of Relapsed/Refractory Mantle Cell Lymphoma

Key Presentations on Multiple Myeloma from Recent Major Oncology/Hematology Conferences

Inside the Issue: Integrating Targeted and Immunotherapy into the Management of Localized Non-Small Cell Lung Cancer

Management of Metastatic Pancreatic Cancer with Dr Michael Pishvaian

Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar

Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 1 of a 4-Part Series

What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma

Practical Perspectives: Investigators Discuss Current Management and Actual Cases of Relapsed/Refractory Metastatic Colorectal Cancer

Blastic Plasmacytoid Dendritic Cell Neoplasm

Inside the Issue: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer

Emerging Role of CELMoDs (Cereblon E3 Ligase Modulators) and Other Novel Approaches to Targeting Protein Degradation Pathways in Multiple Myeloma

Novel Agents and Strategies in the Treatment of Ovarian Cancer

What Clinicians Want to Know About Toxicity Considerations Associated with BTK Inhibitors

Optimizing the Management of Metastatic Pancreatic Cancer

The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma

Meet The Professor: Optimizing the Management of Melanoma

Striving for Consensus: Current and Future Management of Metastatic Non-Small Cell Lung Cancer in Patients Who Experience Disease Progression on Immune Checkpoint Inhibitor Therapy

The Implications of Recent Data Sets for the Management of Hepatocellular Carcinoma

Exploring the Current and Future Management of High-Risk, Hormone-Sensitive Nonmetastatic Prostate Cancer

Role of BTK Inhibitors in Therapy for Mantle Cell Lymphoma

Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 2 of a 2-Part Series

Special Edition — Key Presentations on Chronic Lymphocytic Leukemia and Lymphoma from Recent Major Oncology/Hematology Conferences

Special Edition — Key Presentations on Genitourinary Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Current and Future Management of ER-Positive Metastatic Breast Cancer After Disease Progression on a CDK4/6 Inhibitor

Integrating Bispecific Antibodies into the Management of Multiple Myeloma — Patient Selection and Toxicity Management

Special Edition — Key Presentations on Lung Cancer from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Special Nursing Edition — What I Tell My Patients About New Treatments and Clinical Trials in Chronic Lymphocytic Leukemia

Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers

Special Edition — Key Presentations from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Gastrointestinal Cancers Issue

Special Edition — Key Presentations on Gynecologic Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Ready for Prime Time? Determining the Current and Future Role of PARP Inhibitor-Based Combinations in the Management of Prostate Cancer — A Clinical Investigator Think Tank

Optimizing the Management of Metastatic Urothelial Bladder Cancer

Special Edition — Current and Future Management of Breast Cancer

Special Edition — Key Presentations from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Ovarian Cancer Issue

Special Nursing Edition — What I Tell My Patients About New Treatments and Clinical Trials in Colorectal and Gastroesophageal Cancers

Novel Agents, Approaches and Strategies in the Management of Higher-Risk Myelodysplastic Syndromes

Immune Thrombocytopenia Edition with Dr Hanny Al-Samkari

Paroxysmal Nocturnal Hemoglobinuria Edition with Dr Carlos de Castro

Special Edition — Management of Hepatobiliary Cancers

Special Edition — Management of Urothelial Bladder Cancer

Special Edition — Current and Future Management of Breast Cancer

Special Nursing Edition — What I Tell My Patients About New Treatments and Clinical Trials in Urothelial Bladder Cancer

The Implications of New Research Findings for the Management of Endometrial Cancer

Meet The Professor: The Current and Future Management of Hodgkin and Non-Hodgkin Lymphoma

Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 1 of a 2 - Part Series

Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting: Multiple Myeloma Edition

Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting: Chronic Lymphocytic Leukemia Edition

Key Presentations in Hodgkin and Non-Hodgkin Lymphomas from the 2022 ASH Annual Meeting with Dr Matthew Lunning

Management of Desmoid Tumors with Dr Mrinal Gounder

Management of HER2-Altered Non-Small Cell Lung Cancer

Management of Metastatic Non-Small Cell Lung Cancer without an Actionable Mutation

Key Presentations on Myeloproliferative Neoplasms from the 2022 ASH Annual Meeting — With Dr Srdan Verstovsek

Advances in Diffuse Large B-Cell Lymphoma with Dr Gilles Salles

Key Presentations in Acute Myeloid Leukemia and Myelodysplastic Syndromes from the 2022 ASH Annual Meeting with Dr Richard Stone

Special Edition — Management of ER-Positive Breast Cancer with Drs Erica Mayer and Ruth O'Regan

HER2-Positive Metastatic Breast Cancer with Professor Giuseppe Curigliano

Management of Gastroesophageal Cancers with Dr Manish Shah

Managing Metastatic Urothelial Bladder Cancer with Dr Scott Tagawa